Labeling and Effectiveness Testing: Sunscreen Drug Products for Over-the-Counter Human Use - Notice of Correction

This Notice document was issued by the Food and Drug Administration (FDA)

For related information, Open Docket Folder

Food and Drug Administration
21 CFR Part 201
[Docket No. FDA-1978-N-0018] (formerly Docket No. 1978N-0038)
RIN 0910-AF43

Labeling and Effectiveness Testing; Sunscreen Drug Products for Over-the-Counter Human Use


In rule document 2011-14766 appearing on pages 35620-35665 in the issue of Friday, June 17, 2011, make the following correction:

Regulatory Text

§ 201.327 [Corrected]

In § 201.327, on page 35661, in the third column, § 201.327(i)(1)(ii)(A)(2) and (3) should read as follows:

(2) V i (λ) = 10 0.094 * ( 298 -λ) (298 < λ ≤ 328 nm)

(3) V i (λ) = 10 0.015 * ( 140 -λ) (328 < λ ≤ 400 nm)

[FR Doc. C1-2011-14766 Filed 7-1-11; 8:45 am]
Comment Period Closed
ID: FDA-1978-N-0018-0700
View original printed format:

Document Information

Date Posted: Jul 5, 2011
RIN: 0910-AF43
CFR: 21 CFR Part 201
Federal Register Number: C1-2011-14766
Show More Details  


Comments Received*

Docket Information

This document is contained in

* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.

Document text and images courtesy of the
Federal Register